{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:43:21Z","timestamp":1795121001803,"version":"4.10.3"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    functions as both commensal and pathogen, linking the oral\u2013gut axis to diverse diseases, including cancer. Evidence shows it modulates microbial balance, promotes dysbiosis, and contributes to carcinogenesis by driving inflammation, proliferation, invasion, and immune evasion. This review integrates ecological, molecular, and clinical insights, highlighting its roles in oral and systemic disease and discussing therapeutic potential, underscoring\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    \u2019s dualistic nature and implications for microbiome-targeted interventions.\n                  <\/jats:p>","DOI":"10.1038\/s41522-025-00838-z","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:10:35Z","timestamp":1760454635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Fusobacterium in the microbiome: from health to disease across the oral\u2013gut axis and beyond"],"prefix":"10.1038","volume":"11","author":[{"given":"Zhengrui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2019an","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"838_CR1","first-page":"576","volume":"20","author":"U Hofer","year":"2022","unstructured":"Hofer, U. Fusobacterium orchestrates oral biofilms. Nat. Rev. Microbiol. 20, 576 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"838_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan, C. A. & Garrett, W. S. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 17, 156\u2013166 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"838_CR3","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1128\/IAI.66.10.4729-4732.1998","volume":"66","author":"DJ Bradshaw","year":"1998","unstructured":"Bradshaw, D. J., Marsh, P. D., Watson, G. K. & Allison, C. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect. Immun. 66, 4729\u20134732 (1998).","journal-title":"Infect. Immun."},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4248\/IJOS11025","volume":"3","author":"PE Kolenbrander","year":"2011","unstructured":"Kolenbrander, P. E. Multispecies communities: interspecies interactions influence growth on saliva as sole nutritional source. Int J. Oral. Sci. 3, 49\u201354 (2011).","journal-title":"Int J. Oral. Sci."},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbrc.2023.10.026","volume":"682","author":"Y Karahashi","year":"2023","unstructured":"Karahashi, Y. et al. Fusobacterium nucleatum putatively affects the alveoli by disrupting the alveolar epithelial cell tight junction, enlarging the alveolar space, and increasing paracellular permeability. Biochem. Biophys. Res Commun. 682, 216\u2013222 (2023).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"838_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100813","volume":"31","author":"C Michikawa","year":"2022","unstructured":"Michikawa, C. et al. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1). Neoplasia 31, 100813 (2022).","journal-title":"Neoplasia"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443\u20131448 (2017).","journal-title":"Science"},{"key":"838_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00170-22","volume":"7","author":"A Sakanaka","year":"2022","unstructured":"Sakanaka, A. et al. Fusobacterium nucleatum metabolically integrates commensals and pathogens in oral biofilms. mSystems 7, e0017022 (2022).","journal-title":"mSystems"},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","volume":"6","author":"K Mitsuhashi","year":"2015","unstructured":"Mitsuhashi, K. et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6, 7209\u20137220 (2015).","journal-title":"Oncotarget"},{"key":"838_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2399217","volume":"15","author":"D Li","year":"2024","unstructured":"Li, D., Li, Z., Wang, L., Zhang, Y. & Ning, S. Oral inoculation of Fusobacterium nucleatum exacerbates ulcerative colitis via the secretion of virulence adhesin FadA. Virulence 15, 2399217 (2024).","journal-title":"Virulence"},{"key":"838_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-020-01677-w","volume":"39","author":"P Guo","year":"2020","unstructured":"Guo, P. et al. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J. Exp. Clin. Cancer Res. 39, 202 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"838_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117932","volume":"328","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. et al. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin\/\u03b2-catenin pathway via Fusobacterium nucleatum FadA. J. Ethnopharmacol. 328, 117932 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"25000","DOI":"10.1074\/jbc.M611567200","volume":"282","author":"M Xu","year":"2007","unstructured":"Xu, M. et al. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J. Biol. Chem. 282, 25000\u201325009 (2007).","journal-title":"J. Biol. Chem."},{"key":"838_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2024.04.226","volume":"220","author":"B Li","year":"2024","unstructured":"Li, B. et al. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin\/\u03b2-catenin\/GPX4 axis in colorectal cancer. Free Radic. Biol. Med. 220, 125\u2013138 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"838_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.841918","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Vanillin Derivatives Reverse Fusobacterium nucleatum-Induced Proliferation and Migration of Colorectal Cancer Through E-Cadherin\/\u03b2-Catenin Pathway. Front. Pharm. 13, 841918 (2022).","journal-title":"Front. Pharm."},{"key":"838_CR16","doi-asserted-by":"publisher","unstructured":"Choi, E., Murray, B. & Choi, S. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms241612836 (2023).","DOI":"10.3390\/ijms241612836"},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mib.2014.11.013","volume":"23","author":"YW Han","year":"2015","unstructured":"Han, Y. W. Fusobacterium nucleatum: a commensal-turned pathogen. Curr. Opin. Microbiol. 23, 141\u2013147 (2015).","journal-title":"Curr. Opin. Microbiol."},{"key":"838_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41586-024-07960-6","volume":"633","author":"M Furuichi","year":"2024","unstructured":"Furuichi, M. et al. Commensal consortia decolonize Enterobacteriaceae via ecological control. Nature 633, 878\u2013886 (2024).","journal-title":"Nature"},{"key":"838_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","volume":"51","author":"MT Duong","year":"2019","unstructured":"Duong, M. T., Qin, Y., You, S. H. & Min, J. J. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 51, 1\u201315 (2019).","journal-title":"Exp. Mol. Med."},{"key":"838_CR20","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Fusobacterium nucleatum promotes colorectal cancer through neogenesis of tumor stem cells. J. Clin. Invest. 135, https:\/\/doi.org\/10.1172\/jci181595 (2025).","DOI":"10.1172\/jci181595"},{"key":"838_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591088","volume":"11","author":"M Irfan","year":"2020","unstructured":"Irfan, M., Delgado, R. Z. R. & Frias-Lopez, J. The oral microbiome and cancer. Front. Immunol. 11, 591088 (2020).","journal-title":"Front. Immunol."},{"key":"838_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/ger.12547","volume":"39","author":"K Matthes de Freitas Pontes","year":"2022","unstructured":"Matthes de Freitas Pontes, K. et al. Clinical study of the biofilm of implant-supported complete dentures in healthy patients. Gerodontology 39, 148\u2013160 (2022).","journal-title":"Gerodontology"},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","volume":"31","author":"N Wang","year":"2023","unstructured":"Wang, N. & Fang, J. Y. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol 31, 159\u2013172 (2023).","journal-title":"Trends Microbiol"},{"key":"838_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09587-x","volume":"12","author":"A Idrissi Janati","year":"2022","unstructured":"Idrissi Janati, A. et al. Investigation of Fusobacterium Nucleatum in saliva and colorectal mucosa: a pilot study. Sci. Rep. 12, 5622 (2022).","journal-title":"Sci. Rep."},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40520-020-01521-3","volume":"33","author":"Y Hida","year":"2021","unstructured":"Hida, Y., Nishida, T., Taniguchi, C. & Sakakibara, H. Association between swallowing function and oral bacterial flora in independent community-dwelling elderly. Aging Clin. Exp. Res. 33, 157\u2013163 (2021).","journal-title":"Aging Clin. Exp. Res."},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0378-1135(94)90131-7","volume":"41","author":"KK Amoako","year":"1994","unstructured":"Amoako, K. K., Goto, Y. & Shinjo, T. Studies on the factors affecting the hemolytic activity of Fusobacterium necrophorum. Vet. Microbiol 41, 11\u201318 (1994).","journal-title":"Vet. Microbiol"},{"key":"838_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.anaerobe.2008.12.003","volume":"14","author":"J Strauss","year":"2008","unstructured":"Strauss, J., White, A., Ambrose, C., McDonald, J. & Allen-Vercoe, E. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe 14, 301\u2013309 (2008).","journal-title":"Anaerobe"},{"key":"838_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2514797","volume":"17","author":"MA Zepeda-Rivera","year":"2025","unstructured":"Zepeda-Rivera, M. A., Dewhirst, F. E., Bullman, S. & Johnston, C. D. Addressing controversy in Fusobacterium nomenclature: what exactly does \u201cF. nucleatum\u201d refer to?. Gut Microbes 17, 2514797 (2025).","journal-title":"Gut Microbes"},{"key":"838_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13409","volume":"23","author":"N Michels","year":"2022","unstructured":"Michels, N. et al. Human microbiome and metabolic health: An overview of systematic reviews. Obes. Rev. 23, e13409 (2022).","journal-title":"Obes. Rev."},{"key":"838_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/prd.12296","volume":"83","author":"MA Curtis","year":"2020","unstructured":"Curtis, M. A., Diaz, P. I. & Van Dyke, T. E. The role of the microbiota in periodontal disease. Periodontol 2000 83, 14\u201325 (2020).","journal-title":"Periodontol 2000"},{"key":"838_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185028","volume":"15","author":"MW Dougherty","year":"2023","unstructured":"Dougherty, M. W. & Jobin, C. Intestinal bacteria and colorectal cancer: etiology and treatment. Gut Microbes 15, 2185028 (2023).","journal-title":"Gut Microbes"},{"key":"838_CR32","doi-asserted-by":"publisher","unstructured":"Yamazaki, K. & Kamada, N. Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases. Mucosal. Immunol. https:\/\/doi.org\/10.1016\/j.mucimm.2023.11.006 (2023).","DOI":"10.1016\/j.mucimm.2023.11.006"},{"key":"838_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s13238-018-0548-1","volume":"9","author":"L Gao","year":"2018","unstructured":"Gao, L. et al. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell 9, 488\u2013500 (2018).","journal-title":"Protein Cell"},{"key":"838_CR34","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1128\/IAI.70.8.4609-4620.2002","volume":"70","author":"S Narayanan","year":"2002","unstructured":"Narayanan, S. et al. Fusobacterium necrophorum leukotoxin induces activation and apoptosis of bovine leukocytes. Infect. Immun. 70, 4609\u20134620 (2002).","journal-title":"Infect. Immun."},{"key":"838_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110157","volume":"27","author":"J Galaski","year":"2024","unstructured":"Galaski, J. et al. Fusobacterium nucleatum subsp. nucleatum RadD binds Siglec-7 and inhibits NK cell-mediated cancer cell killing. iScience 27, 110157 (2024).","journal-title":"iScience"},{"key":"838_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2023.102758","volume":"82","author":"AV Robinson","year":"2023","unstructured":"Robinson, A. V. & Allen-Vercoe, E. Strain specificity in fusobacterial co-aggregation with colorectal cancer-relevant species. Anaerobe 82, 102758 (2023).","journal-title":"Anaerobe"},{"key":"838_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744184","volume":"12","author":"D Lamprinaki","year":"2021","unstructured":"Lamprinaki, D. et al. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Front Immunol. 12, 744184 (2021).","journal-title":"Front Immunol."},{"key":"838_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2021.105337","volume":"134","author":"H Morsi","year":"2022","unstructured":"Morsi, H. et al. Detection of Fusobacterium nucleatum subspecies in the saliva of pre-colorectal cancer patients, using tandem mass spectrometry. Arch. Oral. Biol. 134, 105337 (2022).","journal-title":"Arch. Oral. Biol."},{"key":"838_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.815318","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum. Front. Cell Infect. Microbiol 12, 815318 (2022).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"838_CR40","doi-asserted-by":"publisher","first-page":"e85280","DOI":"10.1371\/journal.pone.0085280","volume":"9","author":"P Liu","year":"2014","unstructured":"Liu, P. et al. Detection of fusobacterium nucleatum and fadA adhesin gene in patients with orthodontic gingivitis and non-orthodontic periodontal inflammation. PLoS One 9, e85280 (2014).","journal-title":"PLoS One"},{"key":"838_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.semcancer.2021.11.002","volume":"86","author":"M Stasiewicz","year":"2022","unstructured":"Stasiewicz, M. & Karpinski, T. M. The oral microbiota and its role in carcinogenesis. Semin. Cancer Biol. 86, 633\u2013642 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"838_CR42","first-page":"e34548","volume":"15","author":"SF Louis-Jean","year":"2023","unstructured":"Louis-Jean, S. F., Agrawal, N. & Bisht, S. Fusobacterium nucleatum Pyogenic Liver Abscess and the Role of Bacterial Virulence and Gut Microbiota Dysbiosis. Cureus 15, e34548 (2023).","journal-title":"Cureus"},{"key":"838_CR43","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jfma.2022.01.023","volume":"121","author":"CY Wu","year":"2022","unstructured":"Wu, C. Y., Yu, Z. Y., Hsu, Y. C. & Hung, S. L. Enhancing production of herpes simplex virus type 1 in oral epithelial cells by co-infection with Aggregatibacter actinomycetemcomitans. J. Formos. Med. Assoc. 121, 1841\u20131849 (2022).","journal-title":"J. Formos. Med. Assoc."},{"key":"838_CR44","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1053\/j.gastro.2020.11.034","volume":"160","author":"MA Engevik","year":"2021","unstructured":"Engevik, M. A. et al. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus. Gastroenterology 160, 1301\u20131314.e1308 (2021).","journal-title":"Gastroenterology"},{"key":"838_CR45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1590\/S0034-89102004000500016","volume":"38","author":"J Malheiros Vde","year":"2004","unstructured":"Malheiros Vde, J. & Avila-Campos, M. J. Detection of pathogens from periodontal lesions. Rev. Saude Publica 38, 723\u2013728 (2004).","journal-title":"Rev. Saude Publica"},{"key":"838_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/LBR.0b013e3181a05080","volume":"16","author":"C Ogugua","year":"2009","unstructured":"Ogugua, C. Bilateral lemierre syndrome secondary to periodontitis: a case report and review of the literature. J. Bronchol. Inter. Pulmonol. 16, 115\u2013120 (2009).","journal-title":"J. Bronchol. Inter. Pulmonol."},{"key":"838_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1079-2104(03)00261-0","volume":"96","author":"EL de Sousa","year":"2003","unstructured":"de Sousa, E. L. et al. Bacteriological study of root canals associated with periapical abscesses. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radio. Endod. 96, 332\u2013339 (2003).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radio. Endod."},{"key":"838_CR48","first-page":"156","volume":"57","author":"GL Roberts","year":"2000","unstructured":"Roberts, G. L. Fusobacterial infections: an underestimated threat. Br. J. Biomed. Sci. 57, 156\u2013162 (2000).","journal-title":"Br. J. Biomed. Sci."},{"key":"838_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/omi.12403","volume":"38","author":"R Li","year":"2023","unstructured":"Li, R. et al. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis. Mol. Oral. Microbiol. 38, 9\u201322 (2023).","journal-title":"Mol. Oral. Microbiol."},{"key":"838_CR50","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/ohn.211","volume":"168","author":"K Yan","year":"2023","unstructured":"Yan, K. et al. Microbial changes associated with oral cavity cancer progression. Otolaryngol. Head. Neck Surg. 168, 1443\u20131452 (2023).","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"838_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/carcin\/bgaa062","volume":"42","author":"SC Su","year":"2021","unstructured":"Su, S. C. et al. Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis 42, 127\u2013135 (2021).","journal-title":"Carcinogenesis"},{"key":"838_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.780067","volume":"11","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Alterations of the oral microbiota profiles in Chinese patient with oral cancer. Front Cell Infect. Microbiol. 11, 780067 (2021).","journal-title":"Front Cell Infect. Microbiol."},{"key":"838_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.critrevonc.2019.04.018","volume":"139","author":"D Gopinath","year":"2019","unstructured":"Gopinath, D. et al. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review. Crit. Rev. Oncol. Hematol. 139, 31\u201340 (2019).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"838_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722797","volume":"11","author":"Y Yao","year":"2021","unstructured":"Yao, Y., Shen, X., Zhou, M. & Tang, B. Periodontal pathogens promote oral squamous cell carcinoma by regulating ATR and NLRP3 Inflammasome. Front. Oncol. 11, 722797 (2021).","journal-title":"Front. Oncol."},{"key":"838_CR55","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152891","volume":"22","author":"Q Meng","year":"2021","unstructured":"Meng, Q. et al. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity. EMBO Rep. 22, e52891 (2021).","journal-title":"EMBO Rep."},{"key":"838_CR56","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/dna.2019.5064","volume":"39","author":"F Geng","year":"2020","unstructured":"Geng, F., Zhang, Y., Lu, Z., Zhang, S. & Pan, Y. Fusobacterium nucleatum Caused DNA damage and promoted cell proliferation by the Ku70\/p53 Pathway in Oral Cancer Cells. DNA Cell Biol. 39, 144\u2013151 (2020).","journal-title":"DNA Cell Biol."},{"key":"838_CR57","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/febs.15233","volume":"287","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG\/miR-296-5p\/Akt2\/SNAI1 signaling pathway. FEBS J. 287, 4032\u20134047 (2020).","journal-title":"FEBS J."},{"key":"838_CR58","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.archoralbio.2015.06.017","volume":"60","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells. Arch. Oral. Biol. 60, 1387\u20131393 (2015).","journal-title":"Arch. Oral. Biol."},{"key":"838_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.879423","volume":"12","author":"R Yang","year":"2022","unstructured":"Yang, R. et al. The regulatory effect of coaggregation between Fusobacterium nucleatum and Streptococcus gordonii on the Synergistic Virulence to Human Gingival Epithelial Cells. Front. Cell Infect. Microbiol 12, 879423 (2022).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"838_CR60","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1128\/IAI.68.6.3140-3146.2000","volume":"68","author":"YW Han","year":"2000","unstructured":"Han, Y. W. et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 68, 3140\u20133146 (2000).","journal-title":"Infect. Immun."},{"key":"838_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-024-00326-8","volume":"17","author":"CP Mu\u00f1oz-Grez","year":"2025","unstructured":"Mu\u00f1oz-Grez, C. P. et al. Host-microbe computational proteomic landscape in oral cancer revealed key functional and metabolic pathways between Fusobacterium nucleatum and cancer progression. Int. J. Oral. Sci. 17, 1 (2025).","journal-title":"Int. J. Oral. Sci."},{"key":"838_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1089539","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. The significant clinical correlation of the intratumor oral microbiome in oral squamous cell carcinoma based on tissue-derived sequencing. Front. Physiol. 13, 1089539 (2022).","journal-title":"Front. Physiol."},{"key":"838_CR63","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"838_CR64","doi-asserted-by":"publisher","unstructured":"Chiscuzzu, F. et al. Current evidence on the relation between microbiota and oral cancer-the role of Fusobacterium nucleatum-A Narrative Review. Cancers 17, https:\/\/doi.org\/10.3390\/cancers17020171 (2025).","DOI":"10.3390\/cancers17020171"},{"key":"838_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.795777","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Li, Z., Qi, Y., Wen, X. & Zhang, L. Metagenomic analysis reveals a changing microbiome associated with the depth of invasion of oral squamous cell carcinoma. Front. Microbiol 13, 795777 (2022).","journal-title":"Front. Microbiol"},{"key":"838_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2021.09.013","volume":"164","author":"M Rui","year":"2021","unstructured":"Rui, M. et al. The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study. Radiother. Oncol. 164, 83\u201391 (2021).","journal-title":"Radiother. Oncol."},{"key":"838_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcac006","volume":"4","author":"S Desai","year":"2022","unstructured":"Desai, S. et al. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 4, zcac006 (2022).","journal-title":"NAR Cancer"},{"key":"838_CR68","doi-asserted-by":"publisher","unstructured":"Chen, Z. et al. The intersection between oral microbiota, host gene methylation and patient outcomes in head and neck squamous cell carcinoma. Cancers) 12, https:\/\/doi.org\/10.3390\/cancers12113425 (2020).","DOI":"10.3390\/cancers12113425"},{"key":"838_CR69","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00432-013-1499-9","volume":"139","author":"CC Fan","year":"2013","unstructured":"Fan, C. C. et al. Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J. Cancer Res Clin. Oncol. 139, 1735\u20131744 (2013).","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"838_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1151879","volume":"13","author":"SG Hakim","year":"2023","unstructured":"Hakim, S. G. et al. Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma. Front. Oncol. 13, 1151879 (2023).","journal-title":"Front. Oncol."},{"key":"838_CR71","doi-asserted-by":"publisher","unstructured":"Gopinath, D., Li, Z., Mohammed, M. M. & Panda, S. Role of oral microbes in epithelial-mesenchymal transition in cancer progression. Mol. Oral Microbiol., e70001, https:\/\/doi.org\/10.1111\/omi.70001 (2025).","DOI":"10.1111\/omi.70001"},{"key":"838_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86816-9","volume":"11","author":"C Neuzillet","year":"2021","unstructured":"Neuzillet, C. et al. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Sci. Rep. 11, 7870 (2021).","journal-title":"Sci. Rep."},{"key":"838_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1681972","volume":"2019","author":"W Kang","year":"2019","unstructured":"Kang, W. et al. Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT\/MAPK and NF-kappaB Signaling Pathways in Human Gingival Fibroblasts. Oxid. Med. Cell Longev. 2019, 1681972 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"838_CR74","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fcimb.2019.00429","volume":"9","author":"W Kang","year":"2019","unstructured":"Kang, W., Ji, X., Zhang, X., Tang, D. & Feng, Q. Persistent Exposure to Fusobacterium nucleatum Triggers Chemokine\/Cytokine Release and Inhibits the Proliferation and Osteogenic Differentiation Capabilities of Human Gingiva-Derived Mesenchymal Stem Cells. Front. Cell Infect. Microbiol 9, 429 (2019).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"838_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02062-21","volume":"12","author":"CA Despins","year":"2021","unstructured":"Despins, C. A. et al. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. mBio 12, e0206221 (2021).","journal-title":"mBio"},{"key":"838_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-022-00213-0","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Study of the inflammatory activating process in the early stage of Fusobacterium nucleatum infected PDLSCs. Int. J. Oral. Sci. 15, 8 (2023).","journal-title":"Int. J. Oral. Sci."},{"key":"838_CR77","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1034\/j.1600-051X.2003.00377.x","volume":"30","author":"G Torresyap","year":"2003","unstructured":"Torresyap, G., Haffajee, A. D., Uzel, N. G. & Socransky, S. S. Relationship between periodontal pocket sulfide levels and subgingival species. J. Clin. Periodontol. 30, 1003\u20131010 (2003).","journal-title":"J. Clin. Periodontol."},{"key":"838_CR78","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1902\/jop.2009.090012","volume":"80","author":"A Yoshida","year":"2009","unstructured":"Yoshida, A. et al. Hydrogen sulfide production from cysteine and homocysteine by periodontal and oral bacteria. J. Periodontol. 80, 1845\u20131851 (2009).","journal-title":"J. Periodontol."},{"key":"838_CR79","doi-asserted-by":"publisher","unstructured":"Sun, J. et al. Fusobacterium nucleatum dysregulates inflammatory cytokines and NLRP3 inflammasomes in oral cells. Oral Dis. https:\/\/doi.org\/10.1111\/odi.14899 (2024).","DOI":"10.1111\/odi.14899"},{"key":"838_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202000321","volume":"21","author":"X Xiao","year":"2021","unstructured":"Xiao, X. et al. A qualitative and quantitative analysis of the human gingival crevicular fluid proteome and metaproteome. Proteomics 21, e2000321 (2021).","journal-title":"Proteomics"},{"key":"838_CR81","doi-asserted-by":"publisher","unstructured":"Nogueira, A. V. B. et al. Effect of Bacterial Infection on Ghrelin Receptor Regulation in Periodontal Cells and Tissues. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms23063039 (2022).","DOI":"10.3390\/ijms23063039"},{"key":"838_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-01005-z","volume":"20","author":"H Liu","year":"2022","unstructured":"Liu, H., Liu, Y., Fan, W. & Fan, B. Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis. Cell Commun. Signal 20, 196 (2022).","journal-title":"Cell Commun. Signal"},{"key":"838_CR83","volume":"2","author":"KQ De Andrade","year":"2021","unstructured":"De Andrade, K. Q., Almeida-da-Silva, C. L. C., Ojcius, D. M. & Coutinho-Silva, R. Differential involvement of the canonical and noncanonical inflammasomes in the immune response against infection by the periodontal bacteria Porphyromonas gingivalis and Fusobacterium nucleatum. Curr. Res Micro Sci. 2, 100023 (2021).","journal-title":"Curr. Res Micro Sci."},{"key":"838_CR84","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/JPER.21-0144","volume":"93","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA. J. Periodontol. 93, 515\u2013525 (2022).","journal-title":"J. Periodontol."},{"key":"838_CR85","first-page":"19","volume":"78","author":"M Wilson","year":"1995","unstructured":"Wilson, M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci. Prog. 78, 19\u201334 (1995).","journal-title":"Sci. Prog."},{"key":"838_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19282","volume":"9","author":"RA Bapat","year":"2023","unstructured":"Bapat, R. A. et al. Antimicrobial FiteBac\u00ae K21 promotes antimicrobial Potency and wound healing. Heliyon 9, e19282 (2023).","journal-title":"Heliyon"},{"key":"838_CR87","doi-asserted-by":"publisher","first-page":"e89475","DOI":"10.1371\/journal.pone.0089475","volume":"9","author":"R Bhattacharya","year":"2014","unstructured":"Bhattacharya, R. et al. Effect of bacteria on the wound healing behavior of oral epithelial cells. PLoS One 9, e89475 (2014).","journal-title":"PLoS One"},{"key":"838_CR88","doi-asserted-by":"publisher","unstructured":"Di Spirito, F. et al. Human Herpesviruses, bacteria, and fungi in gingivitis and periodontitis pediatric subjects: a systematic review. Children 12, https:\/\/doi.org\/10.3390\/children12010039 (2024).","DOI":"10.3390\/children12010039"},{"key":"838_CR89","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera, M. et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628, 424\u2013432 (2024).","journal-title":"Nature"},{"key":"838_CR90","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","volume":"67","author":"B Flemer","year":"2018","unstructured":"Flemer, B. et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 67, 1454\u20131463 (2018).","journal-title":"Gut"},{"key":"838_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01526-z","volume":"9","author":"AI Janati","year":"2020","unstructured":"Janati, A. I., Karp, I., Laprise, C., Sabri, H. & Emami, E. Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis. Syst. Rev. 9, 276 (2020).","journal-title":"Syst. Rev."},{"key":"838_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.968649","volume":"13","author":"Z He","year":"2022","unstructured":"He, Z., Tian, W., Wei, Q. & Xu, J. Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review. Front. Immunol. 13, 968649 (2022).","journal-title":"Front. Immunol."},{"key":"838_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-019-1031-7","volume":"8","author":"A Idrissi Janati","year":"2019","unstructured":"Idrissi Janati, A., Karp, I., Sabri, H. & Emami, E. Is a fusobacterium nucleatum infection in the colon a risk factor for colorectal cancer?: a systematic review and meta-analysis protocol. Syst. Rev. 8, 114 (2019).","journal-title":"Syst. Rev."},{"key":"838_CR94","doi-asserted-by":"publisher","unstructured":"Baima, G., Ribaldone, D. G., Romano, F., Aimetti, M. & Romandini, M. The Gum-Gut Axis: Periodontitis and the risk of gastrointestinal cancers. Cancers 15, https:\/\/doi.org\/10.3390\/cancers15184594 (2023).","DOI":"10.3390\/cancers15184594"},{"key":"838_CR95","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2306676","volume":"25","author":"C Ye","year":"2024","unstructured":"Ye, C. et al. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biol. Ther. 25, 2306676 (2024).","journal-title":"Cancer Biol. Ther."},{"key":"838_CR96","doi-asserted-by":"publisher","first-page":"323","DOI":"10.7150\/thno.38870","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Fusobacterium nucleatum promotes metastasis in colorectal cancer by activating autophagy signaling via the upregulation of CARD3 Expression. Theranostics 10, 323\u2013339 (2020).","journal-title":"Theranostics"},{"key":"838_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1299977","volume":"13","author":"J Han","year":"2023","unstructured":"Han, J. et al. Gut microbiome: decision-makers in the microenvironment of colorectal cancer. Front. Cell Infect. Microbiol. 13, 1299977 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"838_CR98","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344\u2013355 (2015).","journal-title":"Immunity"},{"key":"838_CR99","first-page":"32","volume":"1","author":"Z Gao","year":"2025","unstructured":"Gao, Z. et al. Heterogeneity of intratumoral microbiota within the tumor microenvironment and relationship to tumor development. Med Res. 1, 32\u201361 (2025).","journal-title":"Med Res."},{"key":"838_CR100","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","volume":"65","author":"K Mima","year":"2016","unstructured":"Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973\u20131980 (2016).","journal-title":"Gut"},{"key":"838_CR101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207\u2013215 (2013).","journal-title":"Cell Host Microbe"},{"key":"838_CR102","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299\u2013306 (2012).","journal-title":"Genome Res."},{"key":"838_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111127","volume":"40","author":"X Lu","year":"2022","unstructured":"Lu, X. et al. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Cell Rep. 40, 111127 (2022).","journal-title":"Cell Rep."},{"key":"838_CR104","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2295384","volume":"16","author":"C Martin-Gallausiaux","year":"2024","unstructured":"Martin-Gallausiaux, C. et al. Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1\/TIFA axis activation. Gut Microbes 16, 2295384 (2024).","journal-title":"Gut Microbes"},{"key":"838_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28913-5","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Fusobacterium nucleatum reduces METTL3-mediated m(6)A modification and contributes to colorectal cancer metastasis. Nat. Commun. 13, 1248 (2022).","journal-title":"Nat. Commun."},{"key":"838_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18596-0","volume":"8","author":"YY Hsieh","year":"2018","unstructured":"Hsieh, Y. Y. et al. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci. Rep. 8, 158 (2018).","journal-title":"Sci. Rep."},{"key":"838_CR107","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s10620-021-07245-2","volume":"67","author":"X Song","year":"2022","unstructured":"Song, X., Greiner-Tollersrud, O. K. & Zhou, H. Oral microbiota variation: a risk factor for development and poor prognosis of esophageal cancer. Dig. Dis. Sci. 67, 3543\u20133556 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"838_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1057668","volume":"12","author":"D Muszy\u0144ski","year":"2022","unstructured":"Muszy\u0144ski, D. et al. Esophageal cancer and bacterial part of gut microbiota - A multidisciplinary point of view. Front. Cell Infect. Microbiol. 12, 1057668 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"838_CR109","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura, K. et al. Human microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res 22, 5574\u20135581 (2016).","journal-title":"Clin. Cancer Res"},{"key":"838_CR110","doi-asserted-by":"publisher","unstructured":"Guo, S. et al. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2023.08.014 (2023).","DOI":"10.1016\/j.jare.2023.08.014"},{"key":"838_CR111","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2022.01.014","volume":"530","author":"D Nomoto","year":"2022","unstructured":"Nomoto, D. et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1\/RIPK2\/NF-kappaB pathway. Cancer Lett. 530, 59\u201367 (2022).","journal-title":"Cancer Lett."},{"key":"838_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16289-2","volume":"7","author":"N Casta\u00f1o-Rodr\u00edguez","year":"2017","unstructured":"Casta\u00f1o-Rodr\u00edguez, N., Goh, K. L., Fock, K. M., Mitchell, H. M. & Kaakoush, N. O. Dysbiosis of the microbiome in gastric carcinogenesis. Sci. Rep. 7, 15957 (2017).","journal-title":"Sci. Rep."},{"key":"838_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.641322","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang, J., Zhou, X., Liu, X., Ling, Z. & Ji, F. Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment. Front Microbiol 12, 641322 (2021).","journal-title":"Front Microbiol"},{"key":"838_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-021-01260-y","volume":"25","author":"K Ka\u017amierczak-Siedlecka","year":"2022","unstructured":"Ka\u017amierczak-Siedlecka, K., Daca, A., Roviello, G., Catalano, M. & Po\u0142om, K. Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known?. Gastric Cancer 25, 1\u201310 (2022).","journal-title":"Gastric Cancer"},{"key":"838_CR115","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","volume":"20","author":"J Abed","year":"2016","unstructured":"Abed, J. et al. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. Cell Host Microbe 20, 215\u2013225 (2016).","journal-title":"Cell Host Microbe"},{"key":"838_CR116","doi-asserted-by":"publisher","unstructured":"Stasiewicz, M., Kwa\u015bniewski, M. & Karpi\u0144ski, T. M. Microbial associations with pancreatic cancer: a new frontier in biomarkers. Cancers 13, https:\/\/doi.org\/10.3390\/cancers13153784 (2021).","DOI":"10.3390\/cancers13153784"},{"key":"838_CR117","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/cas.15901","volume":"114","author":"M Hayashi","year":"2023","unstructured":"Hayashi, M. et al. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 114, 3666\u20133678 (2023).","journal-title":"Cancer Sci."},{"key":"838_CR118","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semcancer.2022.01.004","volume":"86","author":"TM Karpinski","year":"2022","unstructured":"Karpinski, T. M., Ozarowski, M. & Stasiewicz, M. Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 86, 420\u2013430 (2022).","journal-title":"Semin Cancer Biol."},{"key":"838_CR119","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2022.2145729","volume":"15","author":"Z Fan","year":"2023","unstructured":"Fan, Z. et al. Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. J. Oral. Microbiol 15, 2145729 (2023).","journal-title":"J. Oral. Microbiol"},{"key":"838_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","volume":"145","author":"KL Glassner","year":"2020","unstructured":"Glassner, K. L., Abraham, B. P. & Quigley, E. M. M. The microbiome and inflammatory bowel disease. J. Allergy Clin. Immunol. 145, 16\u201327 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"838_CR121","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3389\/fimmu.2019.01324","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Fusobacterium nucleatum aggravates the progression of Colitis by regulating M1 Macrophage Polarization via AKT2 Pathway. Front Immunol. 10, 1324 (2019).","journal-title":"Front Immunol."},{"key":"838_CR122","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/JPER.22-0205","volume":"94","author":"S Lin","year":"2023","unstructured":"Lin, S. et al. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. J. Periodontol. 94, 405\u2013418 (2023).","journal-title":"J. Periodontol."},{"key":"838_CR123","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"AEV Quaglio","year":"2022","unstructured":"Quaglio, A. E. V., Grillo, T. G., De Oliveira, E. C. S., Di Stasi, L. C. & Sassaki, L. Y. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J. Gastroenterol. 28, 4053\u20134060 (2022).","journal-title":"World J. Gastroenterol."},{"key":"838_CR124","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12876-021-02015-w","volume":"21","author":"X Cui","year":"2021","unstructured":"Cui, X. et al. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterol. 21, 433 (2021).","journal-title":"BMC Gastroenterol."},{"key":"838_CR125","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.14309\/ajg.0000000000001997","volume":"117","author":"MJ Villanueva-Millan","year":"2022","unstructured":"Villanueva-Millan, M. J. et al. Methanogens and hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes. Am. J. Gastroenterol. 117, 2055\u20132066 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"838_CR126","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fmicb.2020.01281","volume":"11","author":"X Gu","year":"2020","unstructured":"Gu, X. et al. Fusobacterium nucleatum causes microbial dysbiosis and exacerbates visceral hypersensitivity in a colonization-independent manner. Front Microbiol 11, 1281 (2020).","journal-title":"Front Microbiol"},{"key":"838_CR127","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12866-021-02380-2","volume":"21","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome. BMC Microbiol. 21, 316 (2021).","journal-title":"BMC Microbiol."},{"key":"838_CR128","doi-asserted-by":"publisher","unstructured":"Simon, E., C\u0103linoiu, L. F., Mitrea, L. & Vodnar, D. C. Probiotics, Prebiotics, and synbiotics: implications and beneficial effects against irritable Bowel Syndrome. Nutrients 13, https:\/\/doi.org\/10.3390\/nu13062112 (2021).","DOI":"10.3390\/nu13062112"},{"key":"838_CR129","doi-asserted-by":"publisher","unstructured":"Di Rosa, C. et al. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 15, https:\/\/doi.org\/10.3390\/nu15071647 (2023).","DOI":"10.3390\/nu15071647"},{"key":"838_CR130","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2021.1887680","volume":"13","author":"M Chung","year":"2021","unstructured":"Chung, M. et al. Comparisons of oral, intestinal, and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases. J. Oral. Microbiol 13, 1887680 (2021).","journal-title":"J. Oral. Microbiol"},{"key":"838_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13646","volume":"25","author":"X Su","year":"2024","unstructured":"Su, X. et al. Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Obes. Rev. 25, e13646 (2024).","journal-title":"Obes. Rev."},{"key":"838_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00476-x","volume":"10","author":"R Kuraji","year":"2024","unstructured":"Kuraji, R. et al. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. NPJ Biofilms Microbiomes 10, 3 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"838_CR133","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/0008-5472.CAN-13-1865","volume":"74","author":"T Tahara","year":"2014","unstructured":"Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311\u20131318 (2014).","journal-title":"Cancer Res."},{"key":"838_CR134","doi-asserted-by":"publisher","first-page":"PR01","DOI":"10.1158\/1538-7445.CRC16-PR01","volume":"77","author":"R Nishihara","year":"2017","unstructured":"Nishihara, R. et al. Abstract PR01: Fusobacterium nucleatum and mutational landscape of colorectal cancer in whole-exome sequencing analysis. Cancer Res. 77, PR01\u2013PR01 (2017).","journal-title":"Cancer Res."},{"key":"838_CR135","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206 (2013).","journal-title":"Cell Host Microbe"},{"key":"838_CR136","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/gutjnl-2022-327156","volume":"72","author":"C Kong","year":"2023","unstructured":"Kong, C. et al. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut 72, 1129\u20131142 (2023).","journal-title":"Gut"},{"key":"838_CR137","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2197836","volume":"15","author":"JW Zhang","year":"2023","unstructured":"Zhang, J. W. et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway. Gut Microbes 15, 2197836 (2023).","journal-title":"Gut Microbes"},{"key":"838_CR138","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2240035","volume":"15","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum-infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellular senescence pathway. Gut Microbes 15, 2240035 (2023).","journal-title":"Gut Microbes"},{"key":"838_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106770","volume":"26","author":"B Tang","year":"2023","unstructured":"Tang, B. et al. MicroRNA-31 induced by Fusobacterium nucleatum infection promotes colorectal cancer tumorigenesis. iScience 26, 106770 (2023).","journal-title":"iScience"},{"key":"838_CR140","doi-asserted-by":"publisher","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt\/beta-catenin modulator Annexin A1. EMBO Rep. 20, https:\/\/doi.org\/10.15252\/embr.201847638 (2019).","DOI":"10.15252\/embr.201847638"},{"key":"838_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.545251","volume":"11","author":"X Li","year":"2020","unstructured":"Li, X. et al. Fusobacterium nucleatum promotes the progression of colorectal cancer through Cdk5-activated Wnt\/beta-Catenin Signaling. Front Microbiol 11, 545251 (2020).","journal-title":"Front Microbiol"},{"key":"838_CR142","doi-asserted-by":"publisher","unstructured":"Pignatelli, P., Nuccio, F., Piattelli, A. & Curia, M. C. The role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis. Microorganisms 11, https:\/\/doi.org\/10.3390\/microorganisms11092358 (2023).","DOI":"10.3390\/microorganisms11092358"},{"key":"838_CR143","doi-asserted-by":"publisher","unstructured":"Engevik, M. A. et al. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio 12, https:\/\/doi.org\/10.1128\/mBio.02706-20 (2021).","DOI":"10.1128\/mBio.02706-20"},{"key":"838_CR144","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.tranon.2019.03.003","volume":"12","author":"J Wu","year":"2019","unstructured":"Wu, J., Li, Q. & Fu, X. Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity. Transl. Oncol. 12, 846\u2013851 (2019).","journal-title":"Transl. Oncol."},{"key":"838_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu, L. et al. Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-kappaB\/S100A9 Cascade. Front Immunol. 12, 658681 (2021).","journal-title":"Front Immunol."},{"key":"838_CR146","doi-asserted-by":"publisher","unstructured":"Koike, R. et al. Heat-Killed Fusobacterium nucleatum triggers varying heme-related inflammatory and stress responses depending on primary human respiratory epithelial cell type. Molecules 25, https:\/\/doi.org\/10.3390\/molecules25173839 (2020).","DOI":"10.3390\/molecules25173839"},{"key":"838_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04183-y","volume":"23","author":"A Lin","year":"2025","unstructured":"Lin, A. et al. Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors. BMC Med. 23, 341 (2025).","journal-title":"BMC Med."},{"key":"838_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105708","volume":"115","author":"Y Situ","year":"2025","unstructured":"Situ, Y. et al. The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy. EBioMedicine 115, 105708 (2025).","journal-title":"EBioMedicine"},{"key":"838_CR149","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","volume":"54","author":"M Liang","year":"2022","unstructured":"Liang, M. et al. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance. Ann. Med. 54, 989\u20131003 (2022).","journal-title":"Ann. Med."},{"key":"838_CR150","doi-asserted-by":"publisher","first-page":"e1581531","DOI":"10.1080\/2162402X.2019.1581531","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur, C. et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology 8, e1581531 (2019).","journal-title":"Oncoimmunology"},{"key":"838_CR151","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00262-018-2233-x","volume":"67","author":"T Chen","year":"2018","unstructured":"Chen, T. et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol. Immunother. 67, 1635\u20131646 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"838_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu, L. et al. Fusobacterium nucleatum Facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-\u03baB\/S100A9 Cascade. Front Immunol. 12, 658681 (2021).","journal-title":"Front Immunol."},{"key":"838_CR153","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","volume":"6","author":"Y Gao","year":"2021","unstructured":"Gao, Y. et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct. Target Ther. 6, 398 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"838_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40987-3","volume":"14","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. Nat. Commun. 14, 5788 (2023).","journal-title":"Nat. Commun."},{"key":"838_CR155","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"SS Jiang","year":"2023","unstructured":"Jiang, S. S. et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe 31, 781\u2013797 e789 (2023).","journal-title":"Cell Host Microbe"},{"key":"838_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1453","volume":"12","author":"T Ugai","year":"2023","unstructured":"Ugai, T. et al. Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD-L1) expression in colorectal carcinoma. Clin. Transl. Immunol. 12, e1453 (2023).","journal-title":"Clin. Transl. Immunol."},{"key":"838_CR157","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2452277","volume":"17","author":"A Lin","year":"2025","unstructured":"Lin, A. et al. From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy. Gut Microbes 17, 2452277 (2025).","journal-title":"Gut Microbes"},{"key":"838_CR158","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1600-051X.1997.tb01837.x","volume":"24","author":"Y Ding","year":"1997","unstructured":"Ding, Y. et al. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J. Clin. Periodontol. 24, 237\u2013248 (1997).","journal-title":"J. Clin. Periodontol."},{"key":"838_CR159","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jre.12023","volume":"48","author":"DA Tipton","year":"2013","unstructured":"Tipton, D. A., Babu, J. P. & Dabbous, M. Effects of cranberry components on human aggressive periodontitis gingival fibroblasts. J. Periodontal Res. 48, 433\u2013442 (2013).","journal-title":"J. Periodontal Res."},{"key":"838_CR160","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/cmi.12554","volume":"18","author":"MN Sztukowska","year":"2016","unstructured":"Sztukowska, M. N. et al. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cell Microbiol 18, 844\u2013858 (2016).","journal-title":"Cell Microbiol"},{"key":"838_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi, L. et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 11, 3259 (2020).","journal-title":"Nat. Commun."},{"key":"838_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/omi.12446","volume":"39","author":"X Guo","year":"2024","unstructured":"Guo, X., Yu, K. & Huang, R. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development. Mol. Oral. Microbiol 39, 1\u201311 (2024).","journal-title":"Mol. Oral. Microbiol"},{"key":"838_CR163","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206 (2013).","journal-title":"Cell Host Microbe"},{"key":"838_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2021.102449","volume":"72","author":"MM Ali Mohammed","year":"2021","unstructured":"Ali Mohammed, M. M., Pettersen, V. K., Nerland, A. H., Wiker, H. G. & Bakken, V. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation. Anaerobe 72, 102449 (2021).","journal-title":"Anaerobe"},{"key":"838_CR165","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2165001","volume":"15","author":"Y Yamaguchi-Kuroda","year":"2023","unstructured":"Yamaguchi-Kuroda, Y., Kikuchi, Y., Kokubu, E. & Ishihara, K. Porphyromonas gingivalis diffusible signaling molecules enhance Fusobacterium nucleatum biofilm formation via gene expression modulation. J. Oral. Microbiol. 15, 2165001 (2023).","journal-title":"J. Oral. Microbiol."},{"key":"838_CR166","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3389\/fmicb.2019.01716","volume":"10","author":"T Thurnheer","year":"2019","unstructured":"Thurnheer, T., Karygianni, L., Flury, M. & Belibasakis, G. N. Fusobacterium Species and Subspecies Differentially Affect the Composition and Architecture of Supra- and Subgingival Biofilms Models. Front Microbiol 10, 1716 (2019).","journal-title":"Front Microbiol"},{"key":"838_CR167","first-page":"62","volume":"1","author":"G Li","year":"2025","unstructured":"Li, G. et al. Breaking boundaries: chronic diseases and the frontiers of immune microenvironments. Med. Res. 1, 62\u2013102 (2025).","journal-title":"Med. Res."},{"key":"838_CR168","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2410478","volume":"16","author":"Z Li","year":"2024","unstructured":"Li, Z., Wang, Q., Huang, X., Wu, Y. & Shan, D. Microbiome\u2019s role in musculoskeletal health through the gut-bone axis insights. Gut Microbes 16, 2410478 (2024).","journal-title":"Gut Microbes"},{"key":"838_CR169","first-page":"813","volume":"62","author":"K Arane","year":"2016","unstructured":"Arane, K. & Goldman, R. D. Fusobacterium infections in children. Can. Fam. Phys. 62, 813\u2013814 (2016).","journal-title":"Can. Fam. Phys."},{"key":"838_CR170","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10096-016-2612-1","volume":"35","author":"T Stergiopoulou","year":"2016","unstructured":"Stergiopoulou, T. & Walsh, T. J. Fusobacterium necrophorum otitis and mastoiditis in infants and young toddlers. Eur. J. Clin. Microbiol Infect. Dis. 35, 735\u2013740 (2016).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"838_CR171","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0163-4453(94)95600-6","volume":"28","author":"I Brook","year":"1994","unstructured":"Brook, I. Fusobacterial infections in children. J. Infect. 28, 155\u2013165 (1994).","journal-title":"J. Infect."},{"key":"838_CR172","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1099\/jmm.0.05441-0","volume":"53","author":"G Haraldsson","year":"2004","unstructured":"Haraldsson, G., Holbrook, W. P. & K\u00f6n\u00f6nen, E. Clonal similarity of salivary and nasopharyngeal Fusobacterium nucleatum in infants with acute otitis media experience. J. Med. Microbiol. 53, 161\u2013165 (2004).","journal-title":"J. Med. Microbiol."},{"key":"838_CR173","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1258\/002221504322731646","volume":"118","author":"W Giridharan","year":"2004","unstructured":"Giridharan, W. et al. Complicated otitis media caused by Fusobacterium necrophorum. J. Laryngol. Otol. 118, 50\u201353 (2004).","journal-title":"J. Laryngol. Otol."},{"key":"838_CR174","doi-asserted-by":"publisher","first-page":"e35622","DOI":"10.1097\/MD.0000000000035622","volume":"102","author":"S Pandey","year":"2023","unstructured":"Pandey, S. et al. Septic thrombophlebitis of portal and splenic vein secondary to Fusobacterium nucleatum: A case report of an abdominal variant of lemierre syndrome. Medicine 102, e35622 (2023).","journal-title":"Medicine"},{"key":"838_CR175","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa585","volume":"8","author":"D Nygren","year":"2021","unstructured":"Nygren, D., Elf, J., Torisson, G. & Holm, K. Jugular Vein Thrombosis and Anticoagulation Therapy in Lemierre\u2019s Syndrome-A Post Hoc Observational and Population-Based Study of 82 Patients. Open Forum Infect. Dis. 8, ofaa585 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"838_CR176","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jmii.2020.03.027","volume":"53","author":"WS Lee","year":"2020","unstructured":"Lee, W. S., Jean, S. S., Chen, F. L., Hsieh, S. M. & Hsueh, P. R. Lemierre\u2019s syndrome: A forgotten and re-emerging infection. J. Microbiol. Immunol. Infect. 53, 513\u2013517 (2020).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"838_CR177","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/CMR.00011-07","volume":"20","author":"T Riordan","year":"2007","unstructured":"Riordan, T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre\u2019s syndrome. Clin. Microbiol. Rev. 20, 622\u2013659 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"838_CR178","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad334","volume":"10","author":"T Kajihara","year":"2023","unstructured":"Kajihara, T. et al. Distribution, Trends, and Antimicrobial Susceptibility of Bacteroides, Clostridium, Fusobacterium, and Prevotella Species Causing Bacteremia in Japan During 2011-2020: A Retrospective Observational Study Based on National Surveillance Data. Open Forum Infect. Dis. 10, ofad334 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"838_CR179","doi-asserted-by":"publisher","first-page":"w30078","DOI":"10.4414\/SMW.2021.w30078","volume":"151","author":"CR Hatz","year":"2021","unstructured":"Hatz, C. R., Cremona, M., Liu, C. C., Schmidlin, P. R. & Conen, A. Antibiotic prophylaxis with amoxicillin to prevent infective endocarditis in periodontitis patients reconsidered: a narrative review. Swiss Med. Wkly 151, w30078 (2021).","journal-title":"Swiss Med. Wkly"},{"key":"838_CR180","doi-asserted-by":"crossref","unstructured":"Shan, D. et al. Identifying Potential Vulnerability to Long COVID Through Global-to-Local Inequalities in Years Lived With Disability Attributed to COVID-19, 2020\u20132021, Across 920 Locations. Med. Res. (2025).","DOI":"10.1002\/mdr2.70023"},{"key":"838_CR181","doi-asserted-by":"publisher","unstructured":"Shan, D. et al. Global, Regional, National, and Local Burden of COVID-19 With Inequality Analysis Across 920 Locations, 2020\u20132021. Med. Res. https:\/\/doi.org\/10.1002\/mdr2.70013 (2025).","DOI":"10.1002\/mdr2.70013"},{"key":"838_CR182","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3201\/eid2703.202284","volume":"27","author":"L Wolff","year":"2021","unstructured":"Wolff, L. et al. COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium. Emerg. Infect. Dis. 27, 975\u2013977 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"838_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00235-2","volume":"7","author":"Y Chu","year":"2021","unstructured":"Chu, Y. et al. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes 7, 66 (2021).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"838_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.888883","volume":"13","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. Association of gut microbiota and biochemical features in a chinese population with renal uric acid stone. Front Pharm. 13, 888883 (2022).","journal-title":"Front Pharm."},{"key":"838_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2016.02.001","volume":"39","author":"E Yusuf","year":"2016","unstructured":"Yusuf, E., Wybo, I. & Pi\u00e9rard, D. Case series of patients with Fusobacterium nucleatum bacteremia with emphasis on the presence of cancer. Anaerobe 39, 1\u20133 (2016).","journal-title":"Anaerobe"},{"key":"838_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10844-z","volume":"23","author":"G Li","year":"2023","unstructured":"Li, G. et al. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer 23, 473 (2023).","journal-title":"BMC Cancer"},{"key":"838_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken, T. J. et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci. Rep. 6, 30751 (2016).","journal-title":"Sci. Rep."},{"key":"838_CR188","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anaerobe.2017.08.010","volume":"48","author":"R Shigefuku","year":"2017","unstructured":"Shigefuku, R. et al. Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer. Anaerobe 48, 144\u2013146 (2017).","journal-title":"Anaerobe"},{"key":"838_CR189","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.imlet.2021.02.007","volume":"232","author":"M Van der Merwe","year":"2021","unstructured":"Van der Merwe, M., Van Niekerk, G., Botha, A. & Engelbrecht, A. M. The onco-immunological implications of Fusobacterium nucleatum in breast cancer. Immunol. Lett. 232, 60\u201366 (2021).","journal-title":"Immunol. Lett."},{"key":"838_CR190","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.clinre.2019.09.001","volume":"44","author":"K Soni","year":"2020","unstructured":"Soni, K., Fricker, Z. & Long, M. T. Pyogenic liver abscesses from Fusobacterium nucleatum in an immunocompetent host. Clin. Res Hepatol. Gastroenterol. 44, e59\u2013e60 (2020).","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"838_CR191","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s42003-024-06201-w","volume":"7","author":"B Udayasuryan","year":"2024","unstructured":"Udayasuryan, B. et al. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner. Commun. Biol. 7, 551 (2024).","journal-title":"Commun. Biol."},{"key":"838_CR192","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/resp.13722","volume":"25","author":"SD Shukla","year":"2020","unstructured":"Shukla, S. D. et al. Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease. Respirology 25, 53\u201363 (2020).","journal-title":"Respirology"},{"key":"838_CR193","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1021\/acsnano.3c12687","volume":"18","author":"S Geng","year":"2024","unstructured":"Geng, S. et al. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer. ACS Nano 18, 8971\u20138987 (2024).","journal-title":"ACS Nano"},{"key":"838_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202306281","volume":"35","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Adv. Mater. 35, e2306281 (2023).","journal-title":"Adv. Mater."},{"key":"838_CR195","doi-asserted-by":"publisher","first-page":"e1008881","DOI":"10.1371\/journal.ppat.1008881","volume":"16","author":"P Kamarajan","year":"2020","unstructured":"Kamarajan, P. et al. Periodontal pathogens promote cancer aggressivity via TLR\/MyD88 triggered activation of Integrin\/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLoS Pathog. 16, e1008881 (2020).","journal-title":"PLoS Pathog."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00838-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:53:07Z","timestamp":1760500387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00838-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":195,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00838-z","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}